BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 37232121)

  • 1. Relevant domains, core outcome sets and measurements for implant dentistry clinical trials: The Implant Dentistry Core Outcome Set and Measurement (ID-COSM) international consensus report.
    Tonetti MS; Sanz M; Avila-Ortiz G; Berglundh T; Cairo F; Derks J; Figuero E; Graziani F; Guerra F; Heitz-Mayfield L; Jung RE; Lai H; Needleman I; Papapanou PN; Sailer I; Sanz-Sanchez I; Schwarz F; Shi J; Thoma D
    Clin Oral Implants Res; 2023 May; 34 Suppl 25():4-21. PubMed ID: 37232121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevant domains, core outcome sets and measurements for implant dentistry clinical trials: The Implant Dentistry Core Outcome Set and Measurement (ID-COSM) international consensus report.
    Tonetti MS; Sanz M; Avila-Ortiz G; Berglundh T; Cairo F; Derks J; Figuero E; Graziani F; Guerra F; Heitz-Mayfield L; Jung RE; Lai H; Needleman I; Papapanou PN; Sailer I; Sanz-Sanchez I; Schwarz F; Shi J; Thoma D
    J Clin Periodontol; 2023 May; 50 Suppl 25():5-21. PubMed ID: 37143289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-stakeholder contribution to the identification of a core outcome set and measurements in implant dentistry (ID-COSM initiative) using the Delphi methodology.
    Sanz M; Carrillo de Albornoz A; Martín C; Needleman I; Tonetti MS
    J Clin Periodontol; 2023 May; 50 Suppl 25():107-121. PubMed ID: 37143293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-stakeholder contribution to the identification of a core outcome set and measurements in implant dentistry (ID-COSM initiative) using the Delphi methodology.
    Sanz M; Carrillo de Albornoz A; Martín C; Needleman I; Tonetti MS
    Clin Oral Implants Res; 2023 May; 34 Suppl 25():108-120. PubMed ID: 37232119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential Domains, Core Outcome Sets, and Measurements to Capture the Benefits and Harms of Implant Dentistry Interventions: The ID-COSM Initiative.
    Tonetti MS; Heitz-Mayfield L; Papapanou PN; Sanz M
    Int J Periodontics Restorative Dent; 2023; 43(5):537-539. PubMed ID: 37733467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Essential Domains, Core Outcome Sets, and Measurements to Capture the Benefits and Harms of Implant Dentistry Interventions: The ID-COSM Initiative.
    Int J Periodontics Restorative Dent; 2023; 43(5):537-539. PubMed ID: 37733466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential domains, core outcome sets, and measurements to capture benefits and harms of implant dentistry interventions: The ID-COSM initiative.
    Tonetti MS; Heitz-Mayfield L; Papapanou PN; Sanz M
    J Periodontol; 2023 Apr; ():. PubMed ID: 37035982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involving people with lived experience in developing a core outcome set for implant dentistry research. The Implant Dentistry-Core Outcomes Sets and Measures (ID-COSM) project.
    Needleman I; Sanz M; de Albornoz AC; Safii S; Hassan NHM; Qian S; Tonetti M
    Clin Oral Implants Res; 2023 May; 34 Suppl 25():97-107. PubMed ID: 37232118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involving people with lived experience in developing a core outcome set for implant dentistry research. The Implant Dentistry-Core Outcomes Sets and Measures (ID-COSM) project.
    Needleman I; Sanz M; Carrillo de Albornoz A; Safii S; Hassan NHM; Qian S; Tonetti M
    J Clin Periodontol; 2023 May; 50 Suppl 25():96-106. PubMed ID: 37143297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core outcomes for pressure ulcer prevention trials: results of an international consensus study: Classification: Outcomes and qualitative research.
    Lechner A; Coleman S; Balzer K; Kirkham JJ; Muir D; Nixon J; Kottner J
    Br J Dermatol; 2022 Nov; 187(5):743-752. PubMed ID: 35789479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e-Delphi process and consensus meeting.
    Langbroek GB; Wolkerstorfer A; Horbach SER; Spuls PI; Kelly KM; Robertson SJ; van Raath MI; Al-Niaimi F; Kono T; Boixeda P; Laubach HJ; Badawi AM; Rubin AT; Haedersdal M; Manuskiatti W; van der Horst CMAM; Ubbink DT;
    Br J Dermatol; 2022 Nov; 187(5):730-742. PubMed ID: 35762296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials.
    Callis Duffin K; Merola JF; Christensen R; Latella J; Garg A; Gottlieb AB; Armstrong AW
    JAMA Dermatol; 2018 Oct; 154(10):1137-1144. PubMed ID: 29874367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring communication as a core outcome in aphasia trials: Results of the ROMA-2 international core outcome set development meeting.
    Wallace SJ; Worrall L; Rose TA; Alyahya RSW; Babbitt E; Beeke S; de Beer C; Bose A; Bowen A; Brady MC; Breitenstein C; Bruehl S; Bryant L; Cheng BBY; Cherney LR; Conroy P; Copland DA; Croteau C; Cruice M; Dipper L; Hilari K; Howe T; Kelly H; Kiran S; Laska AC; Marshall J; Murray LL; Patterson J; Pearl G; Quinting J; Rochon E; Rose ML; Rubi-Fessen I; Sage K; Simmons-Mackie N; Visch-Brink E; Volkmer A; Webster J; Whitworth A; Dorze GL
    Int J Lang Commun Disord; 2023; 58(4):1017-1028. PubMed ID: 36583427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'.
    Prinsen CA; Vohra S; Rose MR; King-Jones S; Ishaque S; Bhaloo Z; Adams D; Terwee CB
    Trials; 2014 Jun; 15():247. PubMed ID: 24962012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice.
    van Geel N; Hamzavi IH; Pandya AG; Wolkerstorfer A; Seneschal J; Garg A; Spuls P; Terwee CB; Mallett S; Speeckaert R; Meurant JM; Eleftheriadou V; Ezzedine K
    Trials; 2022 Jul; 23(1):591. PubMed ID: 35871019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an international core outcome set for treatment trials in necrotizing enterocolitis-a study protocol.
    Klerk DH; van Varsseveld OC; Offringa M; Modi N; Lacher M; Zani A; Pakarinen MP; Koivusalo A; Jester I; Spruce M; Derikx JPM; Bakx R; Ksia A; Vermeulen MJ; Kooi EMW; Hulscher JBF
    Trials; 2023 May; 24(1):367. PubMed ID: 37259112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core outcome research measures in anal cancer (CORMAC): protocol for systematic review, qualitative interviews and Delphi survey to develop a core outcome set in anal cancer.
    Fish R; Sanders C; Williamson PR; Renehan AG
    BMJ Open; 2017 Nov; 7(11):e018726. PubMed ID: 29170292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical research in implant dentistry: study design, reporting and outcome measurements: consensus report of Working Group 2 of the VIII European Workshop on Periodontology.
    Tonetti M; Palmer R;
    J Clin Periodontol; 2012 Feb; 39 Suppl 12():73-80. PubMed ID: 22533948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.